Doctors track heart risks in lung cancer treatment
NCT ID NCT07267247
Summary
This study aimed to understand how often a specific type of heart problem occurs in people with advanced lung cancer who are taking targeted drugs called EGFR-TKIs. Researchers followed 100 patients to monitor their heart function before and during treatment. The goal was to gather information to help doctors better manage potential side effects in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOTOXICITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Taichung Veterans General Hospital
Taichung, 407, Taiwan
Conditions
Explore the condition pages connected to this study.